Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis

Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis

To research and deepen the understanding of the links between morphological tubular kidney lesion parameters and serum markers – neutrophil gelatinase-associated lipocalin (NGAL) and interleukin-18 (IL-18), in patients with chronic glomerulonephritis (CGN) with saved renal function, as well as to es...

Full description

Bibliographic Details
Main Authors:	Dolinna Mariia O., Svyntozelskyi Oleksandr O.
Format:	Article
Language:	English
Published:	Sciendo 2020-03-01
Series:	Current Issues in Pharmacy and Medical Sciences
Subjects:	ngal il-18 glomerulonephritis diagnostics ramipril
Online Access:	https://doi.org/10.2478/cipms-2020-0005

Similar Items

INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL ON INDICATORS OF TUBULO- INTERSTITIAL RENAL DAMAGE IN PATIENTS WITH CKDI-II: GLOMERULONEPHRITIS
by: M.A. Dolinnayä, et al.
Published: (2017-01-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
by: M.A. Dolinnayä, et al.
Published: (2017-03-01)

Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action
by: Dmitriy Vladimirovich Preobrazhenskiy,, et al.
Published: (2009-03-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

Ramipril, an angiotensin-converting enzyme inhibitor, ameliorates oxidative stress, inflammation, and hepatic fibrosis in alloxan-induced diabetic rats
by: Shahnaz Siddiqua, et al.
Published: (2022-12-01)

Ramipril Reduces Acylcarnitines and Distinctly Increases Angiotensin-Converting Enzyme 2 Expression in Lungs of Rats
by: Joanna Kosacka, et al.
Published: (2022-03-01)

SERUM NEUTROPHIL GELATINASE - ASSOCIATED LIPOCALIN (NGAL) AS A MARKER OF TUBULOINTERSTITIAL DAMAGE IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
by: M.A. Dolinnaya
Published: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
by: B J C Onwubere, et al.
Published: (2007-01-01)

Ramipril induced pemphigoid vulgaris
by: Mirza MA, et al.
Published: (2018-09-01)

COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
by: Kateryna Typlynska, et al.
Published: (2023-04-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
by: S. V. Nedogoda
Published: (2016-09-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01)

Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
by: O. D. Ostroumova, et al.
Published: (2013-12-01)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
by: E. E. Averin, et al.
Published: (2019-01-01)

WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective
by: A Aurbach, et al.
Published: (2004-07-01)

COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE
by: I. I. Sinitsina, et al.
Published: (2016-01-01)

Clinical efficacy of losartan and ramipril in male patients with hypertension depending on age, uricemia level, and hypertension type
by: V.P. Ivanov, et al.
Published: (2016-12-01)

Pengaruh Ramipril terhadap Gambaran Mikroskopis Sel Neuron Otak Tikus Wistar yang Mengalami Edema Otak
by: Muhammad Arief Ansyar, et al.
Published: (2022-05-01)

BEBERAPA TIPE LICHEN PLANUS ORAL YANG DIPICU OLEH RAMIPRIL DAN STRES EMOSIONAL (Laporan kasus)
by: Anandina Irmagita, et al.
Published: (2015-08-01)

EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

Pengaruh Ramipril Terhadap Gambaran Histopatologis Otak Tikus Wistar yang Mengalami Edema Otak
by: Rizka Fitria Husni, et al.
Published: (2021-07-01)

Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report
by: Ekta Arora, et al.
Published: (2014-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
by: Katarzyna Regulska, et al.
Published: (2021-10-01)

Determination of ramipril in human plasma and its fragmentation by UPLC-Q-TOF-MS with positive electrospray ionization
by: Szpot Paweł, et al.
Published: (2015-06-01)

EFFICACY AND SAFETY OF FIXED RAMIPRIL + FELODIPINE COMBINATION IN TREATMENT OF ARTERIAL HYPERTENSION: A RETROSPECTIVE STUDY-FORECAST
by: Ivan Tasić, et al.
Published: (2013-03-01)

Comparative effects of parsley leaves aqueous extract and ramipril on gentamicin induced nephrotoxicity in rats
by: Eisha Akram, et al.
Published: (2022-11-01)

NEW ASPECTS OF FIBRILLARY AND IMMUNOTACTOID GLOMERULONEPHRITIS
by: Maurizio Salvadori, et al.
Published: (2019-07-01)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015-12-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016-01-01)

Acute Glomerulonephritis: Clinical and Pathologic Features (Case Report)
by: O.O. Diadyk, et al.
Published: (2016-02-01)

The Role of Urinary Biomarkers as Diagnostic and Prognostic Predictors of Acute Kidney Injury Associated With Vancomycin
by: Durval Sampaio de Souza Garms, et al.
Published: (2021-09-01)

The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats
by: Lin Yun, et al.
Published: (2018-10-01)

CHANGES IN THE PROOXIDATIVE-ANTIOXIDANT SYSTEM IN SHR SERIES RATS WITH TREATMENT OF HYPOTENSIVE MEDICINES (RAMIPRIL AND CANDESARTANE) IN COMBINATION WITH CORVITIN
by: Aliona Marushchak, et al.
Published: (2020-07-01)

Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial
by: Gabor Simonyi
Published: (2016-01-01)